Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ADAP

Adaptimmune Therapeutics (ADAP)

Adaptimmune Therapeutics PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADAP
DateTimeSourceHeadlineSymbolCompany
11/13/20244:19PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADAPAdaptimmune Therapeutics PLC
11/13/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
11/13/20249:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
11/01/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
09/23/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
08/12/20247:23AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADAPAdaptimmune Therapeutics PLC
08/12/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
08/12/20245:47AMIH Market NewsU.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices ClimbNASDAQ:ADAPAdaptimmune Therapeutics PLC
08/02/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
08/01/20248:20PMBusiness WireAdaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid TumorNASDAQ:ADAPAdaptimmune Therapeutics PLC
07/16/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
06/18/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
06/11/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
05/15/20247:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
05/15/20247:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
05/14/20247:34AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
03/06/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
02/27/20248:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
02/16/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/31/20245:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/17/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/17/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/17/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/17/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/17/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/17/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/12/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/12/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/04/20247:46AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
12/06/20237:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:ADAP

Your Recent History

Delayed Upgrade Clock